For a long time, protein kinases have represented an attractive target in oncology drug discovery. However, it is often difficult to find selective agents as the ATP binding pocket is highly conserved.
Choline kinase (ChoK) is the enzyme responsible for the synthesis of phosphocholine (PCho). An increase of PCho molecules within the body can signify tumour progression, so ChoK is considered a promising drug target for cancer therapy.
Read the publication to find out more.
Diamond Light Source is the UK's national synchrotron science facility, located at the Harwell Science and Innovation Campus in Oxfordshire.
Copyright © 2022 Diamond Light Source
Diamond Light Source Ltd
Harwell Science & Innovation Campus
Diamond Light Source® and the Diamond logo are registered trademarks of Diamond Light Source Ltd
Registered in England and Wales at Diamond House, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0DE, United Kingdom. Company number: 4375679. VAT number: 287 461 957. Economic Operators Registration and Identification (EORI) number: GB287461957003.